SG Americas Securities LLC bought a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 21,262 shares of the company's stock, valued at approximately $743,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Murphy & Mullick Capital Management Corp bought a new stake in Option Care Health during the fourth quarter worth $26,000. Signaturefd LLC boosted its holdings in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its holdings in Option Care Health by 434.8% during the first quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company's stock worth $67,000 after buying an additional 1,561 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on the stock. JMP Securities reissued a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research report on Wednesday, June 18th. JPMorgan Chase & Co. increased their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $35.50.
Check Out Our Latest Analysis on OPCH
Option Care Health Stock Performance
Shares of Option Care Health stock traded up $1.21 during trading hours on Tuesday, reaching $32.26. The company had a trading volume of 1,293,418 shares, compared to its average volume of 1,877,660. The firm has a market cap of $5.28 billion, a PE ratio of 26.02, a price-to-earnings-growth ratio of 1.90 and a beta of 0.74. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. The business has a fifty day simple moving average of $32.06 and a 200 day simple moving average of $30.69.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. Option Care Health's revenue was up 16.3% compared to the same quarter last year. During the same period last year, the business earned $0.26 earnings per share. On average, analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.